StockWatch
·
Pharmaceuticals
Quarterly Result14 Feb 2026, 04:53 pm

Concord Drugs Ltd Announces Q3 2025 Financial Results

AI Summary

Concord Drugs Ltd has announced its un-audited standalone and consolidated results for the quarter ended 31st Dec, 2025. The company's Board of Directors considered and approved the financial results for the quarter and nine months ended 31st December, 2025.

Key Highlights

  • Standalone and Consolidated Financial Results for Q3 2025 approved
  • Results available on the company's website and BSE Ltd website
  • Board Meeting commenced at 03:00 PM and concluded at 04:15 PM